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Abstract
During the last 5 years we identified 7 patients with a history of
episodic acute abdominal pain and subobstruction due to intestin-
al angioedema secondary to the use of Angiotensin Converting
Enzyme (ACE) inhibitors. These cases were all diagnosed in one
gastroenterology department. This is thereby the largest single cen-
tre case series of ACE inhibitor-induced angioedema that has been
published until now. Our findings suggest that this syndrome is far
more frequent than international literature would let us believe.
We also describe one of the first male cases diagnosed with this
entity for which there is a significant female predominance. In the
presence of an appropriate history and suggestive findings on CT
scan, this diagnosis can relatively easily be made if one is sufficient-
ly intent on it. An appropriate diagnosis can save these patients a
lot of unnecessary diagnostic procedures and discomfort. (Acta
gastro enterol. belg., 2009, 72, 000-000).
Introduction
Angiotensin Converting Enzyme (ACE) inhibitors are
increasingly used not only as antihypertensive drugs but
also for their general cardiovascular protective effects.
Angioedema is a well known side effect of these drugs
reported to occur in 0.1 to 0.7 percent of patients treat-
ed (1,2,3), typically involving the mouth, lips, tongue,
larynx, pharynx and subglottis. Intestinal angioedema
may also develop but is considered to occur very infre-
quently. Although we could find only few case reports in
the international literature on this subject, we identified
7 cases of ACE inhibitor induced angioedema diagnosed
in a period of 5 years in our gastroenterology department
(Table 1). Our experience suggests that the incidence of
ACE inhibitor-induced intestinal angioedema is probably
more common than is usually believed.  Therefore we
give a short overview of a series of 7 cases diagnosed in
a 5 year period in a single gastroenterology department
(Table 1). Two cases are presented more in detail.
Case series
In a period of 5 years we found 7 patients presenting
on our gastroenterology unit with episodes of abdominal
pain caused by ACE inhibitor induced angioedema.
Referring to table 1 for the general characteristics of all
7 cases, the two most remarkable cases will be described
in detail below. 
The first case is a 42 years old woman with a medical
history of arterial hypertension and an ovarian resection.
In a period of 1 year and 2 months she presented 3l times
to the emergency unit with acute abdominal pain, nausea
en diarrhea. Blood tests showed a raised leucocytosis
(15,100/mm³) and CRP level (28.4 mg/L). CT scan
(Fig. 1) showed an aspecific swelling of the small intes-
tinal wall for which she underwent 3 laparoscopic inter-
ventions, each remaining inconclusive. Even an atypical
presentation of Crohns ileitis was suggested. With a nor-
mal C1 esterase inhibitor and complement level an
abdominal attack of hereditary angioedema was exclud-
ed. Finally, after 1 year and 2 months of unexplained
episodic abdominal pain and diarrhea, the diagnosis of
ACE inhibitor-induced angioedema was suggested. After
stopping the ACE inhibitor, in this case lisinopril, all
complaints disappeared. 
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Fig. 1. — CT-scan of the abdomen in the acute phase with a
small amount of free abdominal fluid (arrow), wall thickening
of a long ileal segment and local edema of the mesenterium.
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and 3). Because of the temporal link between the start of
his complaints and the start of the ACE inhibitor
(perindopril) treatment, ACE inhibitor induced angioede-
ma was included in our differential diagnosis.
Perindopril was immediately stopped and abdominal
pain disappeared. A new CT scan 5 days later showed a
total resolution of the ileal wall changes. 
Discussion
We present here the largest published single centre
case series on ACE inhibitor-induced intestinal
angioedema. We presume therefore that this entity is not
so rare and that it often remains undiagnosed. Lack of
familiarity with the entity can lead to misdiagnosis but
also to repeated invasive procedures and unnecessary
diagnostic testing in patients with recurrent severe symp-
toms as is demonstrated by the first case. 
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The fourth patient is a 53 years old man with a histo-
ry of arterial hypertension, a knee operation, lactase defi-
ciency and COPD (GOLD III), who presented to our
emergency unit with an episodic mesogastric abdominal
pain since a few weeks. Abdominal pain was accompa-
nied by episodes of nausea and vomiting. He was on a
therapy with bisoprolol-hydrochloorthiazide, cloxazo-
lam, butylhyoscinebromide and was started on perindo-
pril since one month. On clinical examination he had a
normal blood pressure, heart rate and temperature, nor-
mal cardiopulmonary auscultation and mesogastric ten-
derness without signs of peritonitis. On abdominal aus-
cultation vivid peristaltic murmurs were heard. 
Blood analysis showed a white blood cell count of
11,700/mm³, CRP level being normal as well as plasma
lactate. Abdominal X-ray showed some prominent small
intestinal loops with unspecific air-fluid levels. An
abdominal CT scan was made and showed sub mucosal
edema of a long intrapelvic segment of the ileum (Figs. 2
Table 1. — Summary of all 7 cases collected in our department in a period of 5 years
Age Sex ACE inhibitor Symptomatic period Time between first presentation 
before diagnosis in our department and diagnosis
Patient 1 42 female Lisinopril 1 year 2 months 1 year and 2 months
Patient 2 51 female Ramipril 4 years 1 day
Patient 3 67 female Lisinopril 2 years 6 months 2 days
Patient 4 53 male Perindopril 1 week 1 day
Patient 5 69 female Perindopril 1 week 2 days
Patient 6 49 female Lisinopril 1 year 1 day
Patient 7 39 female Lisinopril 1 year 1 day
Fig. 2. — CT-scan of the abdomen (with intravenous and oral
contrast). During an acute attack of ACE inhibitor induced
intestinal angioedema, CT-scan shows circumferential trans-
mural thickening of ileal loops producing a target-like lesion
typical of intestinal edema.
Fig. 3. — CT-scan of the abdomen (with intravenous and oral
contrast). Five days after cessation of the ACE inhibitor, CT-
scan shows a total resolution of the previous abnormal findings. 
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ACE inhibitor-induced angioedema is not caused by a
mast cell mediated allergic reaction to ACE inhibitors but
by an ACE inhibitor induced decrease in vasoconstrictive
angiotensin II and an increase in bradykinin causing
vasodilatation and increased vascular permeabili-
ty (1,2,4). This entity appears independently of which
ACE inhibitor is taken (Table 1). The time lag between
the start of the ACE inhibitor treatment and the start of
ACE inhibitor-induced angioedema symptoms is vari-
able. Even though none of our patients had facial or
oropharyngeal symptoms, the presence of intestinal
angioedema does not preclude other clinical manifesta-
tions of angioedema as was illustrated by other case
reports (5).
Very remarkable also is the fact that up to now only
case reports on female patients have been reported.
Although 6 out of 7 of our patients are female, our fourth
case describes one of the first male cases of ACE
inhibitor induced intestinal angioedema that have been
published. Although some authors presume an interac-
tion of oestradiol in the pathogenesis of this disease, the
reason for the remarkable female predominance still
remains unclear (5). Intestinal angioedema causes quite
unspecific episodic periods of diffuse acute abdominal
pain or other symptoms such as diarrhea and vomit-
ing (6,7,8). Since there is no specific diagnostic test for
ACE-inhibitor induced intestinal angioedema, it is
important to think about this entity in all cases of unex-
plained acute abdominal pain in patients taking ACE
inhibitors. Thereby a lot of unnecessary testing can be
avoided. This is also illustrated in Table 1 by the striking
difference in diagnostic lag between the first case and the
more recent ones. The best diagnostic tool is a CT scan
of the abdomen in the acute phase with both oral and
intravenous contrast. It typically shows marked segmen-
tal small bowel wall thickening (target like pattern due to
submucosal edema) along with peritoneal fluid, edema
and vascular engorgement of the local mesenterium. The
list of possible diagnoses based on these radiological
findings is rather limited because of the transient and
segmental nature of the small bowel edema (9). It
includes ischemia, Henoch-Schönlein purpura, intra -
mural bleeding or hereditary angioedema caused by
C1-esterase Inhibitor deficiency (9,10).
Therapy is very simple and cheap since it only con-
sists of discontinuing the ACE inhibitor treatment and
changing it for an adequate alternative. In case of ACE
inhibitor-induced cough these drugs can easily be
switched to angiotensin receptor blockers. However
some data suggest that patients with previous ACE
inhibitor induced angioedema (in general) are more
prone to develop angioedema on angiotensin receptor
blockers too (11). So the latter should only be used if
there is no other alternative.
Conclusion
Although the use of ACE inhibitors has been increas-
ing over the last years, ACE inhibitor-induced intestinal
angioedema still is rarely diagnosed and probably is
underdiagnosed. By reporting on the largest single center
case series of this entity, we wanted to illustrate its clin-
ical importance. The diagnosis of intestinal angioedema
should be considered in every case of acute abdominal
pain of unknown origin in a patient on ACE-inhibitors. A
CT-scan in the acute phase is very useful to provide argu-
ments for or against. A timely diagnosis can save these
patients a lot of unnecessary discomfort and diagnostic
procedures. Although the entity is much more common
in women, the diagnosis of ACE inhibitor induced
angioedema should also be considered in men.
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